Back to Agenda
Session 1: EU Cooperation on HTA – Present and Future
Session Chair(s)
Claudine Sapède, PHARMD
Director, Global HTA Policy, NOVARTIS INTERNATIONAL, Switzerland
Speaker(s)
Flora Giorgio, MPHARM
Head of Unit Medical Devices, DG SANTE – Medical Products and Innovation, European Commission, Belgium
Regulation of the European Parliament and of the Council on health technology assessment and amending Directive 2011/24/EU
Chantal Guilhaume
Scientific Project Manager, Haute Autorité De Santé (HAS), France
EUnetHTA Perspective
Marco Petschulies
Scientific Assessor, G-BA, Germany
The G-BA´s perspective
François Houyez
Treatment Information and Access Director, Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS), France
Patients’ Perspective
Ansgar Hebborn, PHD, MBA
Head - Access Policy Affairs Europe, F. Hoffmann-La Roche AG, Switzerland
Industry Perspective
Have an account?
